Status:
RECRUITING
Identification of Y Chromosome From Free Circulating DNA in Patients With Turner Syndrome
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Turner Syndrome
Eligibility:
FEMALE
2-74 years
Phase:
NA
Brief Summary
Turner syndrome affects 1/2500 female newborns. It is characterized by a short stature, gonadal dysgenesis and bone anomalies. It is secondary to X chromosome abnormality. The clinical course can be m...
Eligibility Criteria
Inclusion
- patient aged 2 to 74 years
- with a diagnosis of Turner syndrome confirmed by karyotype
- who have given their consent or whose legal representative(s) have given their consent(s) consent(s) to participate in the study
- affiliated to the French Social Security system or benefiting from such a system
Exclusion
- male phenotype
- patient or legal representative(s) with comprehension difficulties (linguistic, etc.)
- patients covered by articles L.1121-5 to L.1121-8 of the CSP (French Public Health Code)
Key Trial Info
Start Date :
February 28 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2028
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06202846
Start Date
February 28 2024
End Date
October 1 2028
Last Update
March 6 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospice Civil de Lyon
Lyon, France
2
Hopitaux Universitaire de strasbourg
Strasbourg, France